Serotonin 5-HT1A and dopamin D2 receptor ligands
AssigneeH. Lundbeck A/S
InventorsJens Kristian Perregaard, Ejner Kund Moltzen
Life of this patent
Estimating the term…
Loading patent…
AssigneeH. Lundbeck A/S
InventorsJens Kristian Perregaard, Ejner Kund Moltzen
Estimating the term…
The present invention relates to a series of 4-phenylpiperazines of formula (I) 1 wherein A is alkylene, alkenylene, alkynylene, and C3-7 cycloalkylene; R1 is a C3-10 alkyl, alkenyl, or alkynyl group, cycloalk(en)yl, cycloalk(en)yl-alk(en/yn)yl, trifluoromethylsulfonyl, or alkylsulfonyl, R2-R5 are optional substituents; R9 and R10 are hydrogen, alkyl or together form an ethylene or propylene bridge, W is O or S; V is O, S, CR6R7, or NR8 wherein R6, R7, and R8 are hydrogen or alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, optionally substituted arylalkyl or aryl, or R6 and R7 constitute a 3-7 membered spiro ring; Z is—(CH2)m—; m being 2 or 3 or Z is —CH═CH—; which show effects on central serotonin 5-HT1A and dopamine D2 receptors. Thus the novel compounds are useful in the treatment of certain psychic and neurologic disorders, in particular psychosis.
A 4-phenylpiperazine compound of formula I:
Dependencies are inferred from the claim text.